Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/09/2026 ,inter alia, to consider and approve the proposal for declaration of bonus equity shares to the existing equity shareholders of the Company in accordance with the applicable provisions, subject to approval of the shareholders of the Company.